Early outcome after surgery for active native and prosthetic aortic valve endocarditis

Journal of Heart Valve Disease

Volumn 17, Issue 5, 2008, Pages 508-525

  Gabbieri, Davide ^a   Dohmen, Pascal M ^a   Linneweber, Jörg ^a   Grubitzsch, Herko ^a   Von Heymann, Christian ^b   Neumann, Konrad ^b   Halle, Elke ^b   Konertz, Wolfgang F ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCESS; ADULT; AGED; AORTA VALVE; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOGENIC SHOCK; CAUSE OF DEATH; FEMALE; HEART VALVE REPLACEMENT; HUMAN; INFECTION; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PULMONARY VALVE; REOPERATION; RISK FACTOR; SEPTIC SHOCK; STAPHYLOCOCCUS INFECTION; TRANSPLANTATION;

ABSCESS; ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CAUSE OF DEATH; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; PULMONARY VALVE; REOPERATION; RISK FACTORS; SHOCK, CARDIOGENIC; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 58749094651     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Hill EE, Herijgers P, Herregods MC, Peetermans WE. Evolving trends in infective endocarditis. Clin Microbiol Infect 2006; 12:5-12
2. David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: A continued challenge. J Thorac Cardiovasc Surg 2007; 133:144-149
3. Murashita T, Sugiki H, Kamikubo Y, Yasuda K. Surgical results for active endocarditis with prosthetic valve replacement: Impact of culture-negative endocarditis on early and late outcomes. Eur J Cardiothorac Surg 2004; 26:1104-1111
4. Grinda JM, Mainardi JL, D'Attellis N, et al. Cryopreserved aortic viable homograft for active aortic endocarditis. Ann Thorac Surg 2005; 79-767-771
5. Horstkotte D, Follath F, Gutschik E, et al. Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 2004; 25:267-276
6. Moon MR, Stinson EB, Miller DC. Surgical treatment of endocarditis. Prog Cardiovasc Dis 1997; 40:239-264
7. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-638
8. Renzulli A, Carozza A, Marra C, et al. Are blood and valve cultures predictive for long-term outcome following surgery for infective endocarditis? Eur J Cardiothorac Surg 2000; 17:228-233
9. Clark RE. Definitions of terms of the Society of Thoracic Surgeons National Cardiac Surgery Database. Ann Thorac Surg 1994; 58:271-273
10. Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
11. Pettersson G, Tingleff J, Joyce FS. Treatment of aortic valve endocarditis with the Ross operation. Eur J Cardiothorac Surg 1998; 13:678-684
12. Aranki SF, Santini F, Adams DH, et al. Aortic valve endocarditis. Determinants of early survival and late morbidity. Circulation 1994; 90:II175-II182
13. Gulbins H, Kilian E, Roth S, Uhlig A, Kreuzer E, Reichart B. Is there an advantage in using homo-grafts in patients with acute infective endocarditis of the aortic valve? J Heart Valve Dis 2002; 11: 492-497
14. Konertz W, Tandler R, Hasfeld M, Fahrenkamp A, Breithardt G, Schled HH. Aortic valve replacement with cryopreserved pulmonary allograft. J Card Surg 1994; 9:43-49
15. Niwaya K, Knott-Craig CJ, Santangelo K, Lane MM, Chandrasekaran K, Elkins RC. Advantage of autograft and homograft valve replacement for complex aortic valve endocarditis. Ann Thorac Surg 1999; 67:1603-1608
16. McGiffin DC, Galbraith AJ, McLachlan GJ, et al. Aortic valve infection. Risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1992; 104:511-520
17. Birk E, Sharoni E, Dagan O, et al. The Ross procedure as the surgical treatment of active aortic valve endocarditis. J Heart Valve Dis 2004; 13:73-77
18. Scheld HH, Konertz W. The pathology of biopros-thetic heart valves and allografts. Curr Top Pathol 1994; 86:87-125
19. Konertz W, Dohmen PM, Liu J, et al. Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J Heart Valve Dis 2005; 14:78-81
20. Joyce F, Tingleff J, Aagaard J, Pettersson G. The Ross operation in the treatment of native and prosthetic aortic valve endocarditis. J Heart Valve Dis 1994; 3:371-376
21. Oswalt J. Management of aortic infective endocarditis by autograft valve replacement. J Heart Valve Dis 1994; 3:377-379
22. Konertz WE Stentless aortic xenograft heart valves. Asian Cardiovasc Thorac Ann 2003; 11:1-2
23. Sidiropoulos A, Hotz H, Tschesnow J, Konertz W. Stentless porcine bioprostheses for all types of aortic root pathology. Eur J Cardiothorac Surg 1997; 11:917-921
24. Linneweber J, Kossagk C, Rogge ML, Dushe S, Dohmen P, Konertz W. Clinical experience with the 3F stentless aortic bioprosthesis: One-year follow up. J Heart Valve Dis 2006; 15:545-548
25. Grubitzsch H, Linneweber J, Kossagk C, Sanli E, Beholz S, Konertz WF. Aortic valve replacement with new-generation stentless pericardial valves: Short-term clinical and hemodynamic results. J Heart Valve Dis 2005; 14:623-629
26. Müller LC, Chevtchik O, Bonatti JO, Muller S, Fille M, Laufer G. Treatment of destructive aortic valve endocarditis with the Freestyle aortic root bioprosthesis. Ann Thorac Surg 2003; 75:453-456
27. Siniawski H, Lehmkuhl H, Weng Y, et al. Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg 2003; 75:803-808
28. Aagaard J, Andersen PV. Acute endocarditis treated with radical debridement and implantation of mechanical or stented bioprosthetic devices. Ann Thorac Surg 2001; 71:100-103
29. Bauernschmitt R, Vahl CF, Lange R, Jakob H, Hagl S. Surgical treatment of acute endocarditis of the aortic valve with paravalvular abscess: Considerations justifying the use of mechanical replacement devices. Eur J Cardiothorac Surg 1996; 10:741-747
30. Leyh RG, Knobloch K, Hagl C, et al. Replacement of the aortic root for acute prosthetic valve endocarditis: Prosthetic composite versus aortic allograft root replacement. J Thorac Cardiovasc Surg 2004; 127:1416-1420
31. Langley SM, Alexiou C, Stafford HM, et al. Aortic valve replacement for endocarditis: Determinants of early and late outcome. J Heart Valve Dis 2000; 9:697-704
32. Jault F, Gandjbakhch I, Rama A, et al. Active native valve endocarditis: Determinants of operative death and late mortality. Ann Thorac Surg 1997; 63:1737-1741
33. Mahesh B, Angelini G, Caputo M, Jin XY, Bryan A. Prosthetic valve endocarditis. Ann Thorac Surg 2005; 80:1151-1158
34. Rankin JS, Hammill BG, Ferguson TB, Jr., et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 2006; 131:547-557
35. Balasubramanian SK, Behranwala A, Devbhandari M, et al. Predictors of mortality in early surgical intervention for active native valve endocarditis and significance of antimicrobial therapy: A single-center experience. J Heart Valve Dis 2005; 14:15-22
36. Maeder M, Fehr T, Rickli H, Ammann P. Sepsisassociated myocardial dysfunction: Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006; 129:1349-1366
37. Piper C, Wiemer M, Schulte HD, Horstkotte D. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001; 10:703-711
38. Horstkotte D, Piper C. Management of active infective endocarditis complicated by large vegetations. J Heart Valve Dis 2006; 15:563-566
39. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995; 110:1745-1755
40. Grünenfelder J, Akins CW, Hilgenberg AD, et al. Long-term results and determinants of mortality after surgery for native and prosthetic valve endocarditis. J Heart Valve Dis 2001; 10:694-702
41. Moon MR, Miller DC, Moore KA, et al. Treatment of endocarditis with valve replacement: The question of tissue versus mechanical prosthesis. Ann Thorac Surg 2001; 71:1164-1171
42. Thiele H, Hambrecht R, Lauer B, Weinert M, Mohr FW, Schuler G. Diagnostic value of intraoperative swabs of heart valves in infective endocarditis. J Heart Valve Dis 2001; 10:129-135
43. d'Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z. Long-term results of operation for paravalvular abscess. Ann Thorac Surg 1996; 62:48-53
44. Pompilio G, Brockmann C, Bruneau M, et al. Longterm survival after aortic valve replacement for native active infective endocarditis. Cardiovasc Surg 1998; 6:126-132